Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

BioInnovation Institute reveals new cohort entering Venture Lab programme

September 7, 2022 Research and Development

 The group consists of nine ventures plus two corporate-sponsored innovation projects from Novo Nordisk – all aligned with BII’s focus …
News

New study reveals the range of co-morbidities faced by patients with type 2 diabetes

August 24, 2022 Research and Development

A new study has revealed the range and type of illnesses that people with type 2 diabetes are living with, …
News

Oxford Uni scientists study Siga’s Tpoxx for protection against monkeypox

August 24, 2022 Research and Development

The team at Oxford University, who conducted the landmark RECOVERY trial of COVID-19 therapies, is now studying if Siga Technologies’ …
News

Paediatric Investigation Plan approved by MHRA

August 24, 2022 Research and Development

Northwest Biotherapeutics has announced the approval from the MHRA of the company’s Paediatric Investigation Plan (PIP). The development, regulatory review, …
News

Togo becomes first country to eliminate four neglected tropical diseases

August 24, 2022 Research and Development

WHO has announced that the Republic of Togo has been confirmed as the first country to eliminate four devastating neglected …
News
dna-g009a668c7_1280

Evonetix commences access programme for synthesised DNA

August 17, 2022 Research and Development

Researchers are invited to apply to receive DNA that has been synthesised using Evonetix’s platform Evonetix has announced the opening …
News

Lynparza combination therapy gets FDA priority review for prostate cancer

August 17, 2022 Research and Development

Lynparza is being jointly developed by UK-based AstraZeneca and MSD AstraZeneca’s supplemental new drug application for Lynparza (olaparib) in combination …
News
surgery-1822458_960_720

Successful study to change the blood type of donor kidneys means access for more BAME recipients

August 17, 2022 Research and Development

Scientists at the University of Cambridge have successfully altered the blood type of donor kidneys in a study which could …
News
istockphoto-1266494637-170667a

Patient with HNSCC dosed with triple combination therapy in Phase II of Genexine clinical trial

August 17, 2022 Research and Development

Genexine, a South Korean clinical-staged biopharmaceutical company, have announced the dosing with triple combination therapy of the first patient with …
News
x-ray-6841384__480

Study highlights major factors in shaping cross-disorder cortical abnormalities

August 10, 2022 Research and Development

The study began by constructing maps of cortical abnormalities from thirteen neurodevelopmental, neurological, and psychiatric disorders. These maps came from …
News

Survey reveals 45% of junior doctors are considering leaving the profession

August 10, 2022 Research and Development

1 in 3 (36%) of GPs and 1 in 4 (25%) of specialists surveyed were also looking to pursue a …
News

Karuna Therapeutics announces positive results from Phase III trial into schizophrenia

August 10, 2022 Research and Development

Karuna Therapeutics has announced positive topline results from its Phase III EMERGENT-2 trial, evaluating the efficacy, safety, and tolerability of …
News

Tagrisso combined with Hutchmed drug clears lung cancer test

August 10, 2022 Research and Development

Tagrisso and Hutchmed have revealed positive Phase II data on their combination drug, which prompts the two partners to progress …
News

PCI Pharma Services announces multi-million dollar expansion to UK manufacturing facility

July 27, 2022 Research and Development

PCI has announced a significant expansion of its facility in Tredegar, Wales, UK, designed to help keep up to date …
News

Micronesia’s first COVID outbreak sees steep rise in cases

July 27, 2022 Research and Development

Micronesia’s first outbreak of COVID-19 has grown in one week to over 1,000 cases, causing significant alarm in the Pacific …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026